These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3943191)

  • 21. Thrombin clotting time and fibrinogen concentration in patients treated with coumadin.
    Fricke WA; McDonagh J
    Thromb Res; 1983 Jul; 31(1):23-8. PubMed ID: 6612696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a point of care lateral flow device for measuring human plasma fibrinogen.
    Dudek MM; Lindahl TL; Killard AJ
    Anal Chem; 2010 Mar; 82(5):2029-35. PubMed ID: 20131873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained.
    Brezniak DV; Brower MS; Witting JI; Walz DA; Fenton JW
    Biochemistry; 1990 Apr; 29(14):3536-42. PubMed ID: 2354150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of an abnormal plasma clot structure by a simple rigidity assay.
    Carr ME; Blatt PM; Roberts HR; Brooker JZ; Hermans J
    Thromb Haemost; 1979 Oct; 42(3):965-71. PubMed ID: 505410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors.
    Niewiarowski S; Kirby EP; Brudzynski TM; Stocker K
    Biochemistry; 1979 Aug; 18(16):3570-7. PubMed ID: 476069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombokinetic studies in normal and factor VIII-deficient canine plasmas.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):157-62. PubMed ID: 6603892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unreliability of chromogenic substrates for assay of the clotting activity of thrombin.
    Gaffney PJ; Miller-Andersson M; Kirkwood TB
    Haemostasis; 1978; 7(2-3):109-12. PubMed ID: 566247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaloids of tobacco and blood coagulation: effect of nicotine on thrombin and fibrinogen.
    Singh JM; Singh MD
    Clin Toxicol; 1975; 8(1):43-52. PubMed ID: 1137933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombin reactions with alpha- and gamma-thrombins.
    Chang T; Feinman RD; Landis BH; Fenton JW
    Biochemistry; 1979 Jan; 18(1):113-9. PubMed ID: 420768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms involved in fibrin formation.
    BOYLES PW; FERGUSON JH; MUEHLKE PH
    J Gen Physiol; 1951 May; 34(5):493-513. PubMed ID: 14832433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Human thrombin: enzymatic properties, stability and standardization of preparation].
    Kolodzeĭskaia MV; Chernyshenko TM
    Ukr Biokhim Zh (1999); 2002; 74(5):27-33. PubMed ID: 12916152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release.
    Nawarawong W; Wyshock E; Meloni FJ; Weitz J; Schmaier AH
    Br J Haematol; 1991 Oct; 79(2):296-301. PubMed ID: 1958489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific determination of plasmatic thrombin activity.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
    Muthard RW; Welsh JD; Brass LF; Diamond SL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis.
    Vucelic D; Jesic R; Jovicic S; Zivotic M; Grubor N; Trajkovic G; Canic I; Elezovic I; Antovic A
    Thromb Res; 2015 Jun; 135(6):1124-30. PubMed ID: 25900310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen determination according to Clauss: commutability assessment of International and commercial standards and quality control samples.
    van den Besselaar AMHP; van Rijn CJJ; Cobbaert CM; Reijnierse GLA; Hollestelle MJ; Niessen RWLM; Hudig F
    Clin Chem Lab Med; 2017 Oct; 55(11):1761-1769. PubMed ID: 28412717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperfibrinogenemia as a cause of prolonged thrombin clotting time.
    Carr ME; Gabriel DA
    South Med J; 1986 May; 79(5):563-70. PubMed ID: 3704722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human thrombins. Production, evaluation, and properties of alpha-thrombin.
    Fenton JW; Fasco MJ; Stackrow AB
    J Biol Chem; 1977 Jun; 252(11):3587-98. PubMed ID: 16908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.